课题基金 / 基金详情

Search for cell-death inducing antitumor agents based on the anti-tumor activity of V-ATPase inhibitors

Search for cell-death inducing antitumor agents based on the anti-tumor activity of V-ATPase inhibitors
基于V-ATP酶抑制剂的抗肿瘤活性寻找细胞死亡诱导抗肿瘤药物
批准号:
10557221
负责人:
OHKUMA Shoji
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

OHKUMA Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
本课题研究了V-ATP酶抑制剂如巴弗洛霉素、伴卡那霉素和灵菌菌素促进神经突起生长(NOG)、细胞分化、生长停滞和凋亡的机制,以及V-ATP酶的质子转运机制,发现:(1)V-ATP酶抑制剂如巴弗洛霉素以新的RNA、蛋白质合成和丝氨酸/苏氨酸激酶依赖方式诱导细胞凋亡和NOG;和K-252 a-或A-激酶-独立的方式,但它们彼此不同:细胞凋亡诱导与NOG诱导的不同之处在于其对酪氨酸磷酸酶、花生四烯酸级联反应或钙调蛋白激酶的不敏感性。(2)灵菌红素也能诱导细胞凋亡和NOG,但它们不是由其H^+/Cl^-共转运活性诱导的,(3)NH_4Cl不诱导细胞凋亡或NOG,细胞内外pH差不诱导细胞凋亡或NOG。(4)成功地合成了具有V-ATP酶抑制活性的康卡那霉素A光亲和探针。(5)灵菌红素是一种H^+/Cl^-共转运体,能使ATP酶如F-、V-、P-ATP酶和电子传递活性解偶联,其中灵菌红素抑制质子传递,但不抑制ATP水解(或电子传递)活性。灵菌红素还能强烈地可逆地解偶联(H^+/K^+)ATP酶依赖的猪胃粘膜质子转位。(6)我们成功地克隆了嗜热栖热菌(Thermus termophilus)的V-ATP酶基因,并对其质子泵依赖的ATP合成和操纵子结构进行了研究。
英文摘要
In this project, we have investigated the mechanism of incuction of neurite outgrowth (NOG), cell differentiation, growth inhibiton and apoptosis by inhibitors against V-ATPases, such as bafilomycin, concanamycins and prodigiosins, and the mechanism of proton transport in V-ATPases.We found that (1) V-ATPase inhibitors like bafilomycin induced apoptosis and NOG in new RNA-, protein-syntheses, and serine/threonine kinase-dependent mannaer, and K-252a- or A-kinase-independent manner, but they are different from each other : apoptosis-induction is different from NOG-induction in its insensitivitiy in tyrosin-phosphatase, arachidonate-cascade or Calmodulin-kinase independent manner, (2) apoptosis and NOG are also induced by prodigiosins but they are not induced by its H^+/Cl^- symporting activities, and (3) apoptosis or NOG is not induced by pH-differences between inside and outside of cells, because they are not induced by NH_4Cl, (4) We have succeeded in the synsesis of concanamycin A-photoaffinity probes active in V-ATPase-inhibition. (5) Prodigiosins are H^+/Cl^- symporters that uncoupled ATPases like F-, V-, P-ATPase and electron transport activity, in which prodigiosins inhibited proton-transport but no ATP hydrolysis (or electron transport) activiteis. Prodigiosins also strongly and reversibly uncoupled (H^+/K^+) ATPase-dependent proton-translocation from hog gastric mucosa. (6) We have succeeded in the cloning, proton-pump dependent ATP synthesis, and determation of operon structure of V-ATPase from a eubacterium (Thermus termophilus).
期刊论文(74)
专著(0)
科研奖励(0)
会议论文
大熊 勝治: "細胞生物学実験法 I.細胞培養法"廣川書店. 154 (1999)
大隈胜晴:“细胞生物学实验方法I.细胞培养方法”广川书店154(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishizaki,J.: "Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs."J.Pharmacol.Exptl.Therapeut.. 294. 1088-1098 (2000)
Ishizaki, J.:“体外大鼠肝溶酶体中丙咪嗪的摄取及其受碱性药物的抑制。”J.Pharmacol.Exptl.Therapeut.. 294. 1088-1098 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Konno,H.: "Prodigiosins uncouple mitochondrial and bacterial F-ATPases : evidence for their H^+/Cl^- symport activity."J.Biochem. (Tokyo). 124. 547-556 (1998)
Konno,H.:“灵菌红素解偶联线粒体和细菌 F-ATP 酶:它们的 H^ /Cl^- 同向转运活性的证据。”J.Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishizaki,J.: "Uptake of basic drugs into rat lung granue fraction in vitro."Biol.Pharm.Bull.. 21. 858-861 (1998)
Ishizaki,J.:“体外大鼠肺颗粒部分中碱性药物的摄取。”Biol.Pharm.Bull.. 21. 858-861 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
46
    V-ATPase Inhibitor, pH and Cell Growth Inhibition
    • 批准号:
      14370741
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.13万
    • 财政年份:
      2002
    • 负责人:
      OHKUMA Shoji
    • 依托单位:
    Control mechanisms of autophagy and apoptosis by a new group H^+/Cl^- symporting antibiotics
    • 批准号:
      11470483
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      1999
    • 负责人:
      OHKUMA Shoji
    • 依托单位:
    Mechanism of induction of cell differentiation and cell death by inhibitors against V-ATPase
    • 批准号:
      09672220
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      1997
    • 负责人:
      OHKUMA Shoji
    • 依托单位:
    国内基金
    海外基金
    V-ATPase和S100A10正反馈调控内体pH促进CARDS毒素逆向转运的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黄呈
    • 依托单位:
    溶酶体DOX阻断V-ATPase亚基聚合诱导耐药胶质瘤细胞巨泡式死亡的机制研究
    • 批准号:
      QN25H160010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郭宇航
    • 依托单位:
    V-ATPase 突变通过影响 cGAS-STING 轴阻碍 CCL5 分泌介导滤泡性淋巴瘤荒漠 型肿瘤微环境形成的机制研究
    大补阴丸经GSK-3β/mTORC1/TFEB促进v-ATPase维持溶酶体酸化改善AD认知障碍的机制研究
    • 批准号:
      82304911
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      刘潇
    • 依托单位: